American Century Companies’s Cellebrite CLBT Stock Holding History

American Century Companies's CLBT Position: Q2 2026 in Review

American Century Companies reduced its Cellebrite (CLBT) stake by 13% in Q2 2026, selling an estimated $1.38M and leaving 725,269 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

American Century Companies first reported a position in CLBT in Q1 2025 and has held it in 6 quarters since. The position peaked at $11.4M in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

• American Century Companies held 725,269 shares of Cellebrite worth $10.6M as of Q2 2026.
• American Century Companies sold 104,125 Cellebrite shares in Q2 2026, an estimated $1.38M.
• Cellebrite made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1540 holding.
• American Century Companies first reported a position in Cellebrite in Q1 2025 and has held it in 6 quarters since.
• American Century Companies's Cellebrite position peaked at $11.4M in Q1 2026.
• 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.